Aliases & Classifications for Motion Sickness

MalaCards integrated aliases for Motion Sickness:

Name: Motion Sickness 53 12 40 41 14 69
Travel Sickness 12

Characteristics:

OMIM:

53
Inheritance:
not likely mendelian, but shows familial aggregation


Classifications:



External Ids:

OMIM 53 158280
Disease Ontology 12 DOID:2951
ICD10 32 T75.3
ICD9CM 34 994.6
MeSH 41 D009041
NCIt 46 C34824
MedGen 39 C0026603
SNOMED-CT via HPO 65 88425004
UMLS 69 C0026603

Summaries for Motion Sickness

MedlinePlus : 40 Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Anyone can get it, but it is more common in children, pregnant women, and people taking certain medicines. Motion sickness can start suddenly, with a queasy feeling and cold sweats. It can then lead to dizziness and nausea and vomiting. Your brain senses movement by getting signals from your inner ears, eyes, muscles, and joints. When it gets signals that do not match, you can get motion sickness. For example, if you are reading on your phone while riding a bus, your eyes are focused on something that is not moving, but your inner ear senses motion. Where you sit can make a difference. The front seat of a car, forward cars of a train, upper deck on a boat or wing seats in a plane may give you a smoother ride. Looking out into the distance - instead of trying to read or look at something in the vehicle - can also help. Centers for Disease Control and Prevention

MalaCards based summary : Motion Sickness, also known as travel sickness, is related to space motion sickness and migraine with or without aura 1, and has symptoms including abnormality of the nervous system, medically unexplained symptoms and hypertriglyceridemic waist. An important gene associated with Motion Sickness is HTR3A (5-Hydroxytryptamine Receptor 3A), and among its related pathways/superpathways are Monoamine GPCRs and Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. The drugs Histamine and Diphenhydramine have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and skin, and related phenotypes are Increased transferrin (TF) endocytosis and behavior/neurological

Wikipedia : 72 nausea caused by... more...

Description from OMIM: 158280

Related Diseases for Motion Sickness

Diseases related to Motion Sickness via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 65)
# Related Disease Score Top Affiliating Genes
1 space motion sickness 33.8 AVP TANC1
2 migraine with or without aura 1 29.3 FOS HTR1A HTR3A HTR7 TAC1
3 premature ejaculation 10.4 HTR1A HTR3A
4 psychosexual disorder 10.3 HTR1A HTR7
5 kleptomania 10.3 HTR1A HTR7
6 functional gastric disease 10.3 HTR3A HTR7
7 inappropriate adh syndrome 10.3 AQP1 AVP
8 central pontine myelinolysis 10.3 AQP1 AVP
9 superior mesenteric artery syndrome 10.3 AVP HTR3A
10 impaired renal function disease 10.3 AQP1 AVP
11 intermittent explosive disorder 10.2 HTR1A HTR7
12 dyspepsia 10.2 HTR1A HTR3A
13 mental depression 10.2 HTR1A HTR7
14 neuronitis 10.2
15 rumination disorder 10.1 HTR1A HTR3A HTR7
16 brunner syndrome 10.1 HTR1A HTR3A HTR7
17 aging 10.1
18 central nervous system origin vertigo 10.1
19 generalized anxiety disorder 10.1 HTR1A HTR3A
20 bulimia nervosa 1 10.1 HTR3A HTR7
21 diabetes insipidus, nephrogenic, autosomal 10.1 AQP1 AVP
22 serotonin syndrome 10.0 HTR1A HTR3A TAC1
23 meniere disease 10.0 AQP1 FAM136A
24 alcohol dependence 10.0 HTR1A HTR3A HTR7
25 peripheral vertigo 10.0 AVP FAM136A
26 carney complex, type 1 10.0
27 yaws 10.0
28 vestibular disease 10.0 AVP FAM136A
29 functional diarrhea 10.0 HTR3A HTR7 TAC1
30 irritable bowel syndrome 10.0 HTR3A HTR7 TAC1
31 blood group, i system 9.9
32 episodic pain syndrome, familial, 1 9.9
33 scoliosis 9.9
34 idiopathic scoliosis 9.9
35 allergic hypersensitivity disease 9.9
36 syncope 9.9
37 withdrawal disorder 9.9 FOS HTR7
38 constipation 9.8 HTR3A TAC1
39 thiourea tasting 9.7
40 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 9.7
41 ifap syndrome with or without bresheck syndrome 9.7
42 ataxia and polyneuropathy, adult-onset 9.7
43 helicobacter pylori infection 9.7
44 orthostatic intolerance 9.7
45 anxiety 9.7
46 malaria, mild 9.7
47 glass syndrome 9.7
48 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.7
49 spinal cord injury 9.7
50 thrombosis 9.7

Graphical network of the top 20 diseases related to Motion Sickness:



Diseases related to Motion Sickness

Symptoms & Phenotypes for Motion Sickness

Symptoms via clinical synopsis from OMIM:

53
Neuro:
motion sickness


Clinical features from OMIM:

158280

Human phenotypes related to Motion Sickness:

31
# Description HPO Frequency HPO Source Accession
1 abnormality of the nervous system 31 HP:0000707

UMLS symptoms related to Motion Sickness:


medically unexplained symptoms, hypertriglyceridemic waist, prodromal symptoms, mobility limitation, symptoms, urological manifestations, hot flushes, gastrointestinal gas, vertigo/dizziness, renal colic, chronic pain, polydipsia, chills, vertigo, syncope, skin manifestations, signs and symptoms, respiratory, signs and symptoms, digestive, signs and symptoms, sciatica, pruritus, pelvic pain, pain, oral manifestations, nausea and vomiting, icterus, heartburn, headache, halitosis, fever, fatigue, eye manifestations, edema, dyspepsia, diarrhea, cyanosis, coughing, constipation, chest pain, body temperature changes, asthenia, abdominal pain

GenomeRNAi Phenotypes related to Motion Sickness according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased transferrin (TF) endocytosis GR00363-A 9.23 ADRA2A AVP FOS HTR1A HTR3A HTR7

MGI Mouse Phenotypes related to Motion Sickness:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.81 ADRA2A AQP1 AVP FOS HTR1A HTR3A
2 mortality/aging MP:0010768 9.56 ADRA2A AQP1 AVP EXT2 FOS HTR1A
3 nervous system MP:0003631 9.23 ADRA2A AQP1 AVP FOS HTR1A HTR3A

Drugs & Therapeutics for Motion Sickness

Drugs for Motion Sickness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 82)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Histamine Approved, Investigational Phase 4,Phase 2,Phase 1 51-45-6, 75614-87-8 774
2
Diphenhydramine Approved, Investigational Phase 4 58-73-1, 147-24-0 3100
3
Promethazine Approved, Investigational Phase 4 60-87-7 4927
4
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
5
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
6 Racepinephrine Approved Phase 4 329-65-7
7
Aprepitant Approved, Investigational Phase 4 170729-80-3 6918365 151165
8
Fosaprepitant Approved Phase 4 172673-20-0 219090
9
Ondansetron Approved Phase 4 99614-02-5 4595
10
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
11
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456
12
Meclizine Approved Phase 4,Phase 2,Phase 1 569-65-3 4034
13
Substance P Investigational Phase 4 33507-63-0 44359816
14 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
15 Autonomic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
16 Histamine Antagonists Phase 4,Phase 2,Phase 1
17 Histamine H1 Antagonists Phase 4,Phase 2,Phase 1
18
Histamine Phosphate Phase 4,Phase 2,Phase 1 51-74-1 65513
19 Neurotransmitter Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
20 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
21 Cholinergic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
22 Adjuvants, Anesthesia Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
23 Bromides Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
24 Butylscopolammonium Bromide Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
25 Cholinergic Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
26 Muscarinic Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
27 Mydriatics Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
28 Parasympatholytics Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
29 Scopolamine hydrobromide Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 114-49-8
30 Anesthetics, Local Phase 4
31 Anti-Allergic Agents Phase 4,Phase 2,Phase 1
32 Antiemetics Phase 4,Phase 2,Phase 1
33 Antipruritics Phase 4
34 Central Nervous System Depressants Phase 4
35 Dermatologic Agents Phase 4
36 Gastrointestinal Agents Phase 4,Phase 2,Phase 1
37 Hypnotics and Sedatives Phase 4
38 Epinephryl borate Phase 4
39 glucagon Phase 4
40 Glucagon-Like Peptide 1 Phase 4
41 Hormone Antagonists Phase 4
42 Hormones Phase 4
43 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
44 Hypoglycemic Agents Phase 4
45 Incretins Phase 4
46 Pharmaceutical Solutions Phase 4
47 rGLP-1 protein Phase 4
48
s 1 (combination) Phase 4
49 Anti-Anxiety Agents Phase 4
50 Antipsychotic Agents Phase 4

Interventional clinical trials:

(show all 37)

# Name Status NCT ID Phase Drugs
1 Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels Completed NCT02136420 Phase 4 Promethazine;Placebo
2 A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects Completed NCT02802514 Phase 4 Albiglutide 50mg;Albiglutide matching placebo;Exenatide 10microgram;Exenatide placebo (saline)
3 The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting Completed NCT01897337 Phase 4 Aprepitant;placebo
4 Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting. Completed NCT02286752 Phase 4 Neostigmine;sugammadex
5 Motion Sickness Medications and Vestibular Time Constant Recruiting NCT03270839 Phase 4 Bonine 25Mg Chewable Tablet;Kwells;Placebo Oral Tablet
6 Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria Completed NCT00785135 Phase 3
7 Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray Terminated NCT02155309 Phase 2, Phase 3 Scopolamine;Placebo
8 Levo Phencynonate Hydrochloride for the Prevention of Seasickness Completed NCT02241629 Phase 2 placebo;levo phencynonate hydrochloride
9 Effects of Transdermal Scopolamine on Occupational Performance Completed NCT00374478 Phase 2 Scopolamine
10 Meclizine as a Potential Smoking Cessation Treatment Completed NCT01443858 Phase 2 Meclizine;Nicotine Patch;Placebo
11 Phase II Dose-ranging Study of APD421 in PONV Completed NCT01510704 Phase 2 APD421;Placebo
12 Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV) Completed NCT00895830 Phase 2 APD405;Placebo
13 A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. Completed NCT02839135 Phase 1 Reformulated scopolamine patch;Marketed scopolamine patch
14 Meclizine for Hepatocellular Carcinoma Recruiting NCT03253289 Phase 1 Meclizine Oral Tablet
15 A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness Unknown status NCT01198106 scopolamine;cinnarizine
16 Parabolic Flight Induced Neuroplasticity Studied With Advanced Magnetic Resonance Imaging Methods Unknown status NCT02517216
17 Influence of Gravity on the Perception of Egocentric Distance (Blindpulling) Unknown status NCT02508545
18 Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers Completed NCT02177890
19 Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? Completed NCT00360282 Rizatriptan
20 Study of Hierarchy of Afferents in Postural Control of Children With Dyslexia Completed NCT02879786
21 Risk Factors for Post Operative Nausea and Vomiting(PONV) in Patients Underwent Gynecological Operation Under General Anesthesia Completed NCT01020201
22 Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI Completed NCT01379001 Scopolamine;Placebo;Donepezil
23 Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia Completed NCT02416115 Ramosetron;Naloxone;saline;Morphine
24 Virtual Reality Distraction for Procedural Pain Management and Anxiety in Children With Burn Injuries : A Pilot Study Completed NCT02794103
25 Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation Recruiting NCT02986555
26 Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe Recruiting NCT02911402
27 Risk Factors for Postoperative Nausea, Vomiting and Pruritus Recruiting NCT03178058
28 Effects of Inverted Vision on Pointing and Grasping in Parabolic Flight Recruiting NCT02885844
29 Transcranial Electrical Stimulation for Mal de Debarquement Syndrome Recruiting NCT02540616
30 Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome Recruiting NCT02470377
31 The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression Recruiting NCT02849639 Early Phase 1 Scopolamine patch
32 Influence of Couch Tracking Motion Recruiting NCT02820532
33 Predictive Progressive Factors of Adolescent Idiopathic Scoliosis Recruiting NCT02862392
34 Virtual Reality in Labor and Delivery for Reduction in Pain Not yet recruiting NCT03437031
35 The Effect of Gum Chewing on Postoperative Ileus Withdrawn NCT00879294
36 Intraoperative Electronic Reminder Module to Enhance Postoperative Nausea and Vomiting Prophylaxis Withdrawn NCT02830412
37 Rescue Emetic Therapy for Children Having Elective Surgery Withdrawn NCT01067677 Metaclopramide;Ondansetron;diphenhydramine;Saline

Search NIH Clinical Center for Motion Sickness

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: motion sickness

Genetic Tests for Motion Sickness

Anatomical Context for Motion Sickness

MalaCards organs/tissues related to Motion Sickness:

38
Eye, Brain, Skin, Heart, Testes, Liver, Amygdala

Publications for Motion Sickness

Articles related to Motion Sickness:

(show top 50) (show all 620)
# Title Authors Year
1
Allocating less attention to central vision during vection is correlated with less motion sickness. ( 29325490 )
2018
2
Acupuncture relieves motion sickness via the IRI^-ERK1/2-dependent insulin receptor signalling pathway. ( 29436382 )
2018
3
Higher Asymmetry Ratio and Refixation Saccades in Individuals with Motion Sickness. ( 29401064 )
2018
4
Predicting vection and visually induced motion sickness based on spontaneous postural activity. ( 29181555 )
2018
5
Effect of Prophylactic Medication on Associated Dizziness and Motion Sickness in Migraine. ( 29227453 )
2018
6
Reduction of Motion Sickness Through Targeting Histamine<i>N</i>-Methyltransferase in the Dorsal Vagal Complex of the Brain. ( 29298819 )
2018
7
Motion sickness increases functional connectivity between visual motion and nausea-associated brain regions. ( 28245927 )
2017
8
Determinants of Motion Sickness in Tilting Trains: Coriolis/Cross-Coupling Stimuli and Tilt Delay. ( 28555125 )
2017
9
Prevalence, Predictors, and Prevention of Motion Sickness in Zero-G Parabolic Flights. ( 28061915 )
2017
10
Brain Activation by H1 Antihistamines Challenges Conventional View of Their Mechanism of Action in Motion Sickness: A Behavioral, c-Fos and Physiological Study in Suncus murinus (House Musk Shrew). ( 28659825 )
2017
11
Orientation Preferences and Motion Sickness Induced in a Virtual Reality Environment. ( 28923138 )
2017
12
A Historical View of Motion Sickness-A Plague at Sea and on Land, Also with Military Impact. ( 28421029 )
2017
13
Cross-coupling vestibular stimulation: motion sickness and the vestibulo-sympathetic reflex. ( 28455665 )
2017
14
Correlations between individual susceptibility to visually induced motion sickness and decaying time constant of after-nystagmus. ( 28502398 )
2017
15
Effects of Physical Driving Experience on Body Movement and Motion Sickness During Virtual Driving. ( 29046173 )
2017
16
Low level of swiprosin-1/EFhd2 in vestibular nuclei of spontaneously hypersensitive motion sickness mice. ( 28128226 )
2017
17
The efficacy of airflow and seat vibration on reducing visually induced motion sickness. ( 28634889 )
2017
18
Effects of decades of physical driving on body movement and motion sickness during virtual driving. ( 29121059 )
2017
19
Electroacupuncture Could Reduce Motion Sickness Susceptibility in Healthy Male Adults: A Double-Blinded Study. ( 29279732 )
2017
20
Vection is the main contributor to motion sickness induced by visual yaw rotation: Implications for conflict and eye movement theories. ( 28380077 )
2017
21
Effect of exposure to short-wavelength light on susceptibility to motion sickness. ( 28538515 )
2017
22
History of High Motion Sickness Susceptibility Predicts Vestibular Dysfunction Following Sport/Recreation-Related Concussion. ( 29189336 )
2017
23
Passive restraint reduces visually induced motion sickness in older adults. ( 28150962 )
2017
24
Storage of passive motion pattern in hippocampal CA1 region depends on CaMKII/CREB signaling pathway in a motion sickness rodent model. ( 28230177 )
2017
25
Sex and Age Differences in Motion Sickness in Rats: The Correlation with Blood Hormone Responses and Neuronal Activation in the Vestibular and Autonomic Nuclei. ( 28261089 )
2017
26
Meniere's, migraine, and motion sickness. ( 27918236 )
2016
27
Psychometric Properties of the Greek Version of the Gianaros Motion Sickness Assessment Questionnaire. ( 27779955 )
2016
28
Effects of naloxone on motion sickness in cats alone and with broad spectrum antiemetics. ( 27615675 )
2016
29
The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness. ( 27160425 )
2016
30
Motion sickness and sopite syndrome associated with parabolic flights: a case report. ( 26624575 )
2016
31
EEG Alpha and Gamma Modulators Mediate Motion Sickness-Related Spectral Responses. ( 26790485 )
2016
32
Subjective Vertical Conflict Theory and Space Motion Sickness. ( 26802378 )
2016
33
The influence of sleep deprivation and oscillating motion on sleepiness, motion sickness, and cognitive and motor performance. ( 27641791 )
2016
34
The virtual reality head-mounted display Oculus Rift induces motion sickness and is sexist in its effects. ( 27915367 )
2016
35
Motion Sickness and Resting Energy Expenditure in Chinese Male Adults. ( 27026119 )
2016
36
Biodynamic Hypothesis for the Frequency Tuning of Motion Sickness. ( 26735236 )
2016
37
Motion Sickness Prediction in Aeromedical Evacuation of Patients with Ebola. ( 26735238 )
2016
38
Motion sickness in ancient China: Seasickness and cart-sickness. ( 27432177 )
2016
39
Vestibular evoked myogenic potentials and motion sickness medications. ( 27178852 )
2016
40
Moving in a Moving World: A Review on Vestibular Motion Sickness. ( 26913019 )
2016
41
Evaluation of Motion Sickness Induced by 3D Video Clips. ( 26832611 )
2016
42
Contribution of intra-vestibular sensory conflict to motion sickness and dizziness in migraine disorders. ( 27385797 )
2016
43
Motion sickness. ( 27638085 )
2016
44
AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat. ( 26651338 )
2015
45
Using bio-signals to evaluate multi discomfort in image viewing - balancing visually induced motion sickness and field of view. ( 26737708 )
2015
46
Relationship between Spectral Characteristics of Spontaneous Postural Sway and Motion Sickness Susceptibility. ( 26657203 )
2015
47
Formulation of Eco-friendly Medicated Chewing Gum to Prevent Motion Sickness. ( 25652732 )
2015
48
A Medical Food Formulation of Griffonia simplicifolia/Magnesium for Childhood Periodic Syndrome Therapy: An Open-Label Study on Motion Sickness. ( 25590358 )
2015
49
Sex differences in visual performance and postural sway precede sex differences in visually induced motion sickness. ( 26466829 )
2015
50
Quantitative orientation preference and susceptibility to space motion sickness simulated in a virtual reality environment. ( 25647233 )
2015

Variations for Motion Sickness

Expression for Motion Sickness

Search GEO for disease gene expression data for Motion Sickness.

Pathways for Motion Sickness

GO Terms for Motion Sickness

Biological processes related to Motion Sickness according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signal transduction GO:0007165 9.88 ADRA2A AVP EXT2 HTR1A HTR3A HTR7
2 G-protein coupled receptor signaling pathway GO:0007186 9.77 ADRA2A AVP HTR1A HTR7 TAC1
3 chemical synaptic transmission GO:0007268 9.61 HTR3A HTR7 TAC1
4 cellular response to hormone stimulus GO:0032870 9.46 ADRA2A FOS
5 renal water homeostasis GO:0003091 9.32 AQP1 AVP
6 water transport GO:0006833 9.26 AQP1 AVP
7 adenylate cyclase-inhibiting serotonin receptor signaling pathway GO:0007198 9.16 HTR1A HTR7
8 positive regulation of saliva secretion GO:0046878 8.96 AQP1 TAC1
9 vasoconstriction GO:0042310 8.8 AVP HTR1A HTR7

Molecular functions related to Motion Sickness according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neurotransmitter receptor activity GO:0030594 9.16 HTR1A HTR7
2 G-protein coupled serotonin receptor activity GO:0004993 8.96 HTR1A HTR7
3 serotonin binding GO:0051378 8.8 HTR1A HTR3A HTR7

Sources for Motion Sickness

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....